Pfizer said the Food and Drug Administration approved Tukysa as a front-line maintenance treatment for people with a form of breast cancer.
Breast cancer is one of the most common cancers in adolescents and young adults under age 39, and the rate is rising fastest ...
The FDA approved Pfizer’s Tukysa with trastuzumab and pertuzumab as front-line maintenance treatment for adults with ...
TUKYSA in combination with trastuzumab and pertuzumab showed more than 50% improvement in median progression-free survival, ...
A breast cancer surgeon and plastic surgeon share advice for navigating a confusing and emotional time ...
The FDA approved tucatinib (Tukysa; Pfizer) in combination with trastuzumab and pertuzumab for the maintenance treatment of ...
Breast cancer care can be harder to access for rural, Black and underserved Georgians. Here's what experts and community ...
CHI Health hosted its 16th annual ladies night on Wednesday, celebrating those impacted by the disease as they gathered to ...
Tanji Patton said her recovery from cancer treatment is progressing more slowly than expected in a new YouTube video on Oct.
The World Health Organization reports that breast cancer was the most common form of the disease among women in 164 of 186 ...
Mississippi is among the top three states in the nation for breast cancer deaths, according to the state health department, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results